Skip to main content

Go Premium in Our Biggest Sale Ever

UPGRADE NOW
TipRanks
Go Ultimate75% OFF

Celularity (CELU) Stock Price & Analysis

220 Followers

CELU Stock Chart & Stats

$0.71-$0.05(-6.45%)
At close: 4:00 PM EST
$1$1.5$2Aug 17Aug 31Sep 14Sep 28Oct 12Oct 26Nov 9
Day’s Range
$0.71 - $0.76
52-Week Range
$0.56 - $2.55
Previous Close
$0.76
Volume
N/A
Average Volume (3M)
155.49K
Market Cap
$23.07M
Enterprise Value
$116.37M
Total Cash (Recent Filing)
$586.00K
Total Debt (Recent Filing)
$36.02M
Price to Earnings (P/E)
―
Beta
3.30
Next Earnings
Apr 01, 2027 (Est.)
EPS Estimate
N/A
Next Dividend Ex-Date
N/A
Dividend Yield
N/A

Bulls Say, Bears Say

Bulls Say

New Peptide Manufacturing Platform

The Vesalius collaboration expands Celularity’s manufacturing role beyond its existing regenerative-medicine focus into peptide APIs. If executed successfully, this could diversify revenue, improve utilization of its cGMP capabilities, and create a more durable commercial platform.

Key Nasdaq Compliance Restored

Restoring compliance with two important Nasdaq standards removes immediate delisting pressure and supports continued access to public capital markets. This improves operating stability and investor access, although the separate delayed-filing deficiency still requires resolution.

Cash Burn Has Improved

The reduction in cash outflows indicates better cash discipline than in earlier periods, while positive free-cash-flow growth suggests progress in controlling spending. Continued improvement could extend liquidity and reduce funding needs, even though cash generation remains negative.

Bears Say

Severe Revenue And Profitability Pressure

The sharp revenue contraction leaves the company’s cost structure far above its current sales base, producing substantial operating and net losses. Unless revenue recovers or costs reset structurally, the business is unlikely to reach break-even and earnings visibility will remain weak.

Negative Equity And Strained Balance Sheet

Negative equity means the company lacks a positive capital cushion to absorb additional losses, while debt further limits financial flexibility. The shrinking asset base and strained capital structure increase refinancing pressure and can force reliance on dilution or secured financing.

Financing Carries Dilution And Security Risk

The financing provides capital but adds expensive secured obligations and conversion-related dilution risk. Claims over substantially all assets can constrain future flexibility, while additional shares or conversions may reduce existing holders’ ownership as the company funds ongoing losses.

Celularity News

CELU FAQ

What was Celularity’s price range in the past 12 months?
Celularity lowest stock price was $0.56 and its highest was $2.55 in the past 12 months.
What is Celularity’s market cap?
Celularity’s market cap is $23.07M.
When is Celularity’s upcoming earnings report date?
Celularity’s next earnings report is estimated for Mar 26, 2026 (not yet confirmed), which is 230 days ago.
How were Celularity’s earnings last quarter?
Celularity released its earnings results on Aug 18, 2025. The company reported -$1.02 earnings per share for the quarter, missing the consensus estimate of -$0.75 by -$0.27.
Is Celularity overvalued?
Not enough analysts have published a price target to calculate whether the price is overvalued.
Does Celularity pay dividends?
Celularity does not currently pay dividends.
What is Celularity’s EPS estimate?
Celularity’s EPS estimate is -1.50.
How many shares outstanding does Celularity have?
Celularity has 32,450,680 shares outstanding.
What happened to Celularity’s price movement after its last earnings report?
Celularity reported an EPS of -$1.02 in its last earnings report, missing expectations of -$0.75. Following the earnings report the stock price went down -0.826%.
Which hedge fund is a major shareholder of Celularity?
Hedge funds hold Celularity shares: the largest hedge-fund position in Celularity is 71,887,424 shares, and hedge funds decreased their holdings by 51.1K shares last quarter.
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology